CN Patent

CN102427728A — 用硫代秋水仙碱衍生物进行联合治疗

Assigned to Abraxis Bioscience LLC · Expires 2012-04-25 · 14y expired

What this patent protects

本发明提供治疗增生性疾病(如，癌症)的联合治疗方法，包括给个体施用有效量的秋水仙碱或硫代秋水仙碱二聚体和抗-VEGF抗体。该方法还包括施用有效量的紫杉烷。秋水仙碱或硫代秋水仙碱二聚体和紫杉烷(如，紫杉醇)可以以纳米颗粒，如包含药物和载体蛋白，如白蛋白的纳米颗粒的形式存在。

USPTO Abstract

本发明提供治疗增生性疾病(如，癌症)的联合治疗方法，包括给个体施用有效量的秋水仙碱或硫代秋水仙碱二聚体和抗-VEGF抗体。该方法还包括施用有效量的紫杉烷。秋水仙碱或硫代秋水仙碱二聚体和紫杉烷(如，紫杉醇)可以以纳米颗粒，如包含药物和载体蛋白，如白蛋白的纳米颗粒的形式存在。

Drugs covered by this patent

Patent Metadata

Patent number
CN102427728A
Jurisdiction
CN
Classification
—
Expires
2012-04-25
Drug substance claim
No
Drug product claim
No
Assignee
Abraxis Bioscience LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.